Topics
Latest
AI
Amazon
Image Credits:Ataraxis AI
Apps
Biotech & Health
clime
Image Credits:Ataraxis AI
Cloud Computing
Commerce
Crypto
enterprisingness
EVs
Fintech
Fundraising
appliance
Gaming
Government & Policy
Hardware
Layoffs
Media & Entertainment
Meta
Microsoft
Privacy
Robotics
surety
Social
Space
Startups
TikTok
transit
Venture
More from TechCrunch
event
Startup Battlefield
StrictlyVC
Podcasts
Videos
Partner Content
TechCrunch Brand Studio
Crunchboard
get through Us
Artificial intelligence is a big vogue in cancer concern , and it ’s mostly focused on detecting Crab at the earliest possible stage . That have a raft of sense , given that cancer is less deathly the before it ’s observe .
But few are asking another cardinal head : If someone does have cancer , is an aggressive treatment like chemotherapy necessary ? That ’s the job Ataraxis AI is render to solve .
The New York - base inauguration is rivet on using AI to accurately predict not only if a patient has Crab , but also what their cancer final result count like in five to 10 years . If there ’s only a small luck of the Crab coming back , chemo can be avoided altogether — saving a lot of money , while avoiding the treatment ’s ill-famed side effects .
Ataraxis AI now plan to set up their first commercial-grade run , for breast cancer , to U.S. oncologists in the follow months , its co - founder Jan Witowski tells TechCrunch . To bolster the launching and flourish into other type of cancer , the startup has heighten a $ 20.4 million Series A , it told TechCrunch exclusively .
The rhythm was lead by AIX Ventures with participation from Thiel Bio , Founders Fund , Floating Point , Bertelsmann , and existing investor Giant Ventures and Obvious Ventures . Ataraxisemergedfrom stealth last year with a $ 4 million seed round .
Ataraxis was co - base by Witowski and Krzysztof Geras , an adjunct professor at NYU ’s aesculapian school who focuses on AI .
Ataraxis ’ technical school is powered by an AI model that distil info from high - resolve look-alike of genus Cancer cells . The model is trained on hundreds of millions of real images from thousands of patients , Witowski say . A recent field read Ataraxis ’ technical school was 30 % more accurate than the current criterion of fear for white meat Crab , per Ataraxis .
Join us at TechCrunch Sessions: AI
Exhibit at TechCrunch Sessions: AI
Long terminal figure , Ataraxis has big dream . It need its mental test to touch on at least one-half of new cancer cases by 2030 . It also reckon itself as a frontier AI company that builds its own models , toutingMeta ’s primary AI scientist Yann LeCunas an AI adviser .
“ I mean at Ataraxis we are trying to build what is essentially an AI frontier science laboratory , but for healthcare applications , ” Witowski say . “ Because so many of those trouble require a very fresh technology . ”
The AI roaring has led to a rush of fundraises for cancer aid startups . Valar Labsraised $ 22 millionto help patient figure out their treatment programme in May 2024 , for example . There ’s also a bevy of AI - power drug find firms in the cancer distance , like Manas AI , whichraised $ 24.6 million in January 2025and was co - found by Reid Hoffman , the LinkedIn Centennial State - founder .
